Clinical Trial Update: The Paclitaxel (Albumin-bound) Combined With Cisplatin, PD-1 Inhibitors and IMRT in the Treatment of Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating paclitaxel albumin-bound with cisplatin, PD-1 inhibitors, and IMRT in nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• IMRT
• PD-1 inhibitors
• Paclitaxel (albumin-bound) (paclitaxel albumin-bound)

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN